A pH-sensitive nanocomposite microsphere based on chitosan and montmorillonite with in vitro reduction of the burst release effect

被引:28
作者
Hua, Shuibo [1 ,2 ]
Yang, Huixia [1 ,2 ]
Wang, Aiqin [1 ]
机构
[1] Chinese Acad Sci, Lanzhou Inst Chem Phys, Ctr Ecomat & Green Chem, Lanzhou 730000, Peoples R China
[2] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China
关键词
Chitosan; drug release; montmorillonite; nanocomposite; ofloxacin; MULTIVESICULAR LIPOSOMES; VIVO EVALUATION; DRUG-RELEASE; DELIVERY;
D O I
10.3109/03639041003677798
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Objective: The aim of this study was to prepare pH-sensitive ofloxacin (OFL)/montmorillonite (MMT)/chitosan (CTS) nanocomposite microspheres that improve the burst release effect of the drug by the solution intercalation technique and emulsification cross-linking techniques. Methods: First, OFL/MMT hybrids were prepared through the solution intercalation technique. Then, OFL/MMT-intercalated OFL/MMT/CTS nanocomposite microspheres were obtained through emulsification cross-linking technology. The intercalated nanocomposite was confirmed by Fourier-transform infrared spectroscopy and X-ray diffraction. Finally, in vitro release of OFL from the microspheres was performed in simulated gastric fluids and simulated intestinal fluids. The effect of MMT content on drug encapsulation efficiency and the drug release of the nanocomposite microspheres were investigated. Results: The results showed that the release rate of OFL from the nanocomposite microspheres at pH 7.4 was higher than that at pH 1.2. Compared with pure CTS microspheres, the incorporation of certain amount of MMT in the nanocomposite microspheres can enhance the drug encapsulation efficiency and reduce the burst release. Conclusion: A sustained release particulate system can be obtained by incorporating MMT into the nanocomposite microspheres and can improve the burst release effect of the drug.
引用
收藏
页码:1106 / 1114
页数:9
相关论文
共 30 条
[1]   Controlled release of clozapine through chitosan microparticles prepared by a novel method [J].
Agnihotri, SA ;
Aminabhavi, TM .
JOURNAL OF CONTROLLED RELEASE, 2004, 96 (02) :245-259
[2]   Use of clays as drug delivery systems: Possibilities and limitations [J].
Aguzzi, C. ;
Cerezo, P. ;
Viseras, C. ;
Caramella, C. .
APPLIED CLAY SCIENCE, 2007, 36 (1-3) :22-36
[3]   5-fluorouracil-loaded chitosan microspheres: Preparation and release characteristics [J].
Akbuga, J ;
Bergisadi, N .
JOURNAL OF MICROENCAPSULATION, 1996, 13 (02) :161-168
[4]   N-Trimethyl chitosan-coated multivesicular liposomes for oxymatrine oral delivery [J].
Cao, Jinna ;
Sun, Jukui ;
Wang, Xiaoyu ;
Li, Xinran ;
Deng, Yingjie .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2009, 35 (11) :1339-1347
[5]   In vitro and in vivo evaluation of ofloxacin sustained release pellets [J].
Cui, Yue ;
Zhang, Yu ;
Tang, Xing .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 360 (1-2) :47-52
[6]   Cell proliferation and controlled drug release studies of nanohybrids based on chitosan-g-lactic acid and montmorillonite [J].
Depan, Dilip ;
Kumar, Annamalai Pratheep ;
Singh, Raj Pal .
ACTA BIOMATERIALIA, 2009, 5 (01) :93-100
[7]   Release of cationic drugs from loaded clay minerals [J].
Fejér, I ;
Kata, M ;
Erös, I ;
Berkesi, O ;
Dékány, I .
COLLOID AND POLYMER SCIENCE, 2001, 279 (12) :1177-1182
[8]   ESTABLISHMENT OF SINK CONDITIONS IN DISSOLUTION RATE DETERMINATIONS - THEORETICAL CONSIDERATIONS AND APPLICATION TO NONDISINTEGRATING DOSAGE FORMS [J].
GIBALDI, M ;
FELDMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1967, 56 (10) :1238-&
[9]   Synthesis and characterization of chitosan-MMT biocomposite systems [J].
Gunister, Ebru ;
Pestreli, Dilay ;
Unlu, Cuneyt H. ;
Atici, Oya ;
Gungor, Nurfer .
CARBOHYDRATE POLYMERS, 2007, 67 (03) :358-365